Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Details 4)

v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Details 4) - shares
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Convertible notes and accrued interest    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 7,582,318 7,616,305
Stock options and warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 62,826,514 44,688,591